Conquering Diseases

Testing Nurown To Treat Als

Description

This study will evaluate the effectiveness and safety of repeat administrations of NurOwn injections as compared to Placebo given three times two months apart to participants with ALS. The study will consist of a pre-treatment period of up to 5 months, treatment period for 4 months and a follow up period of 3 months.

Overview

The objective of this study is to find out the safety of a repeated use of the drug called NurOwn. We will whether it may decrease the rate of decline of the disease without causing too many side effects. To do this, study doctors will remove some of your bone marrow cells, treat them in a laboratory, and put them back into the fluid that surrounds the spinal cord. This study and cell treatment only involve cells from your body.

What we're hoping for

The purpose of the study is to evaluate the safety and effectiveness of the stem cell treatment as a treatment for ALS

Additional Information

ClinicalTrials.gov Identifier: NCT03280056

 Principal Investigator

Robert H Brown, MD, PhD

UMass Chan Medical School

 Study Contact

Catherine  Douthwright

508-856-6491

Catherine.Douthwright@umassmed.edu

 Location

UMMH Memorial Campus

281 Lincoln St. 

Worcester,MA 01605

508-334-1000